loadpatents
name:-0.053071975708008
name:-0.021010875701904
name:-0.00062084197998047
HORWELL; David Christopher Patent Filings

HORWELL; David Christopher

Patent Applications and Registrations

Patent applications and USPTO patent grants for HORWELL; David Christopher.The latest application filed is for "pyrimidine derivatives for the treatment of amyloid-related diseases".

Company Profile
0.13.11
  • HORWELL; David Christopher - Cambridge GB
  • Horwell; David Christopher - Foxton GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Pyrimidine Derivatives For The Treatment Of Amyloid-related Diseases
App 20130059871 - HORWELL; David Christopher ;   et al.
2013-03-07
Pyridine Derivatives For The Treatment Of Amyloid-related Diseases
App 20100298325 - Scopes; David Ian Carter ;   et al.
2010-11-25
Pyrimidine Derivatives For The Treatment Of Amyloid-related Diseases
App 20100063077 - Horwell; David Christopher ;   et al.
2010-03-11
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
Grant 7,122,678 - Bryans , et al. October 17, 2
2006-10-17
Conformationally constrained compounds as pharmaceutical agents
App 20050250800 - Bryans, Justin Stephen ;   et al.
2005-11-10
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
Grant 6,921,835 - Bryans , et al. July 26, 2
2005-07-26
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
App 20050159487 - Bryans, Justin Stephen ;   et al.
2005-07-21
Aromatic amides
Grant 6,846,953 - Bryans , et al. January 25, 2
2005-01-25
Novel amines as pharmaceutical agents
App 20030229054 - Belliotti, Thomas Richard ;   et al.
2003-12-11
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
App 20030220397 - Bryans, Justin Stephen ;   et al.
2003-11-27
Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
Grant 6,635,673 - Bryans , et al. October 21, 2
2003-10-21
Conformationally constrained compounds as pharmaceutical agents
App 20030119858 - Bryans, Justin Stephen ;   et al.
2003-06-26
4(3)substituted-4(3)-aminomethyl-(thio)pyran or piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
Grant 6,545,022 - Bryans , et al. April 8, 2
2003-04-08
NK1 receptor antagonists
App 20030065007 - Creswell, Mark Wallace ;   et al.
2003-04-03
1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
Grant 6,518,289 - Bryans , et al. February 11, 2
2003-02-11
Conformationally constrained compounds as pharmaceutical agents
Grant 6,489,352 - Bryans , et al. December 3, 2
2002-12-03
Conformationally constrained compounds as pharmaceutical agents
App 20020019540 - Bryans, Justin Stephen ;   et al.
2002-02-14
Branched alkyl pyrrolidine-3-carboxylic acids
Grant 6,245,801 - Bryans , et al. June 12, 2
2001-06-12
Low molecular weight dendritic compounds as pharmaceutical agents
Grant 6,225,352 - Horwell , et al. May 1, 2
2001-05-01
Non-peptide bombesin receptor antagonists
Grant 6,194,437 - Horwell , et al. February 27, 2
2001-02-27
Substituted cyclic amino acids as pharmaceutical agents
Grant 6,103,932 - Horwell , et al. August 15, 2
2000-08-15
Peripherally selective kappa opioid agonists
Grant 6,057,357 - Horwell , et al. May 2, 2
2000-05-02
Bridged cyclic amino acids as pharmaceutical agents
Grant 6,020,370 - Horwell , et al. February 1, 2
2000-02-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed